Filtrer par Last updated date SelectAprèsAvantFrom - To Date Date de fin Cette semaine Ce mois Semaine dernière Mois dernier Category HumanCorporateVeterinaryHerbal Topic MedicinesCOVID-19PharmacovigilanceVaccinesReferralsPaediatricsRare diseasesRegulatory and procedural guidanceClinical trialsAdvanced therapiesData on medicinesCompliance and inspectionsInnovationMedicine shortagesResearch and developmentBiosimilarsSMEAntimicrobial resistanceCorporateGovernanceBrexitQuality of medicinesGeneric and hybrid medicinesEarly accessMedicines for use outside the EUFeesProduct informationScientific adviceMedical devicesMaximum residue limitMpoxBiologicalsScientific guidelinesVeterinary limited marketsCompassionate useCareersMedication errorPRIMEParallel distributionProcurement Diseases area Viral diseasesCancerImmune-system diseasesDiabetesNeurodegenerative diseasesCardiovascular diseasesHIV and AIDS Responsible body CHMP CVMP PRAC Management Board COMP PDCO CMDh HMPC CAT Patient safety information Patient safety Laisser ce champ vide Filter Résultats (3827) Sort by Last update date (new to old)Last update date (old to new)A-ZZ-A Laisser ce champ vide First EMEA workshop with industry on Orphan Medicinal Products 25 avril 2001Press releaseHumanRare diseases Committee for veterinary medicinal products: 65th meeting 19 avril 2001Press releaseVeterinary EMEA Public Statement on the Recommendation to suspend the marketing authorisation for Orlaam (Levaceetylmethadol) in the European Union 19 avril 2001News 12th meeting of the Committee for Orphan Medicinal Products 17 avril 2001Press releaseHumanRare diseases 1st EMEA workshop for patients' organisations on Orphan Medicinal Products 5 avril 2001Press releaseHumanRare diseases 69th meeting of the Committee for Proprietary Medicinal Products (CPMP) 3 avril 2001Press release 11th meeting of the Committee for Orphan Medicinal Products 28 mars 2001Press releaseHumanRare diseases Meeting of the EMEA working party on herbal medicinal products 13 - 14 March 2001 23 mars 2001Press releaseHerbal Committee for veterinary medicinal products: 64th meeting 15 mars 2001Press releaseVeterinary European Medicines Agency public statement on Leflunomide (Arava) - Severe and serious hepatic reactions 12 mars 2001NewsMedicines 1 … 359 360 361 362 363 Page 363 of 383 364 365 366 367 … 383
First EMEA workshop with industry on Orphan Medicinal Products 25 avril 2001Press releaseHumanRare diseases
EMEA Public Statement on the Recommendation to suspend the marketing authorisation for Orlaam (Levaceetylmethadol) in the European Union 19 avril 2001News
12th meeting of the Committee for Orphan Medicinal Products 17 avril 2001Press releaseHumanRare diseases
1st EMEA workshop for patients' organisations on Orphan Medicinal Products 5 avril 2001Press releaseHumanRare diseases
11th meeting of the Committee for Orphan Medicinal Products 28 mars 2001Press releaseHumanRare diseases
Meeting of the EMEA working party on herbal medicinal products 13 - 14 March 2001 23 mars 2001Press releaseHerbal
European Medicines Agency public statement on Leflunomide (Arava) - Severe and serious hepatic reactions 12 mars 2001NewsMedicines